Literature DB >> 2138777

Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.

B Formby1, N Miller.   

Abstract

We investigated by flow cytometric analysis the expression of class II major histocompatibility complex (MHC) molecules by viable single-cell islet cells (SCICs) prepared from male and female 4- and 10-week-old nonobese diabetic (NOD) mouse islets. With anti-I-Ak monoclonal antibody (specific for I-Ak,f,r,s beta and produced by clone 11-5-2), and fluorescein isothiocyanate-conjugated goat anti-mouse IgG as second-step antibody, we found that SCICs from both sexes aberrantly expressed class II MHC molecules, which was not altered after SCICs were cultured for 24 hr or 120 hr in the presence of 10 ng of recombinant murine interferon gamma per ml. Double-indirect immunofluorescence of male SCICs indicated that the expression of class II MHC molecules was a property of beta cells. Control experiments documented that macrophages and mononuclear cells did not contaminate the SCIC preparations. Coculture experiments with responder splenic CD4 T cells isolated from diabetic NOD mice and stimulator male SCICs indicated a recognition event evidenced by a 12-fold increase in proliferative response. Monoclonal antibodies to class II MHC and CD4 antigens blocked the proliferative response. Results from control autologous and allogeneic mixed lymphocyte reactions suggest that the responder CD4 T cells are autoreactive self-class II MHC restricted. We tentatively conclude that the ability of SCICs from both sexes of NOD mice to express class II MHC molecules as early as 4 weeks of age may represent a mechanism for targeting immune reactions to beta cells and initiate lymphocytic insulitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138777      PMCID: PMC53704          DOI: 10.1073/pnas.87.7.2438

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The preparation of, and studies on, free cell suspensions from mouse pancreatic islets.

Authors:  A Lernmark
Journal:  Diabetologia       Date:  1974-10       Impact factor: 10.122

Review 2.  Genetics and expression of mouse Ia antigens.

Authors:  L Mengle-Gaw; H O McDevitt
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

3.  Lectin-induced expression of DR antigen on human cultured follicular thyroid cells.

Authors:  R Pujol-Borrell; T Hanafusa; L Chiovato; G F Bottazzo
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

4.  Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells.

Authors:  B M Dean; R Walker; A J Bone; J D Baird; A Cooke
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

5.  Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.

Authors:  R Jansson; A Karlsson; U Forsum
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

6.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

7.  Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

Authors:  G F Bottazzo; R Pujol-Borrell; T Hanafusa; M Feldmann
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

8.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

9.  Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis.

Authors:  G Ballardini; R Mirakian; F B Bianchi; E Pisi; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

10.  MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.

Authors:  E H Leiter; G J Christianson; D V Serreze; A T Ting; S M Worthen
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Non-obese diabetic transgenic mouse.

Authors:  K Yamamura; T Miyazaki; M Uno; T Toyonaga; J Miyazaki
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Retrovirus gag protein p30 in the islets of non-obese diabetic mice: relevance for pathogenesis of diabetes mellitus.

Authors:  C Nakagawa; T Hanafusa; J Miyagawa; M Yutsudo; H Nakajima; K Yamamoto; K Tomita; N Kono; A Hakura; S Tarui
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

3.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Authors:  A Rivard; M Silver; D Chen; M Kearney; M Magner; B Annex; K Peters; J M Isner
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

4.  Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.

Authors:  E Strandell; S Sandler; C Boitard; D L Eizirik
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

5.  Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.

Authors:  Irma Pujol-Autonell; Rosa-Maria Ampudia; Raquel Planas; Silvia Marin-Gallen; Jorge Carrascal; Alex Sanchez; Ana Marin; Manuel Puig-Domingo; Ricardo Pujol-Borrell; Joan Verdaguer; Marta Vives-Pi
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.